Back to Results
First PageMeta Content
Cancer treatments / Afamelanotide / Light therapy / Erythropoietic protoporphyria / Squamous-cell carcinoma / Photodynamic therapy / Actinic keratosis / Management of cancer / Phototoxicity / Medicine / Oncology / Peptide hormones


Document Date: 2012-04-19 14:38:23

Open Document

File Size: 56,90 KB

Share Result on Facebook

City

Melbourne / Paris / Marseille / /

Company

Clinuvel Pharmaceuticals Limited / Corporate Development Clinuvel Pharmaceuticals Limited / /

Country

France / Australia / /

/

Event

FDA Phase / /

IndustryTerm

biopharmaceutical / common cancer treatment / other cancer therapies / cancer treatment / pharmaceutical products / /

MedicalCondition

anaphylactic reaction / cancers / Actinic Keratosis / skin burns / Squamous Cell Carcinoma / common cancer / cancer / skin disorders / Patients (OTP) Solar Urticaria / phototoxicity / burns of the skin / tumour / Indication Erythropoietic Protoporphyria / erythema / acute blistering / nearby cancer / Gliomas / pain / associated phototoxicity / bile duct cancer / erythropoietic protoporphyria / UV-related skin disorders / /

MedicalTreatment

Photodynamic Therapy / adjunctive therapy / cancer therapies / Organ Transplant / radiation / /

Person

Philippe Wolgen / /

/

Position

CEO / Colin Mackie Head / /

Product

UR9 / Photodynamic Therapy / /

Technology

radiation / /

URL

www.clinuvel.com / /

SocialTag